At Hayek Medical Devices (HMD), we are united by a shared mission to support patients, clinicians, and care teams through thoughtful innovation in noninvasive respiratory support. Our team works collaboratively to advance awareness, education, and appropriate use of Biphasic Cuirass Ventilation (BCV)—a patented, externally applied ventilation modality developed to expand noninvasive options across care settings.
BCV utilizes a non-invasive cuirass shell applied to the thorax to deliver externally generated pressure changes that support ventilation and assist with secretion clearance, when prescribed by a healthcare professional. By avoiding an airway interface, BCV offers an alternative noninvasive approach for patients who may not tolerate mask-based or invasive ventilation strategies.
BCV is used across a wide range of care environments worldwide, including hospitals, long-term acute care facilities, and many care settings. Guided by the original vision of Dr. Zamir Hayek, HMD continues to support clinical education, responsible adoption, and independent research as BCV is integrated into respiratory care pathways.